in

27-Year-Old Engineer Dies After Developing Blood Clot on Brain Following Covid Vaccine

27-Year-Old Engineer Dies After Developing Blood Clot on Brain Following Covid Vaccine
27-Year-Old Engineer Dies After Developing Blood Clot on Brain Following Covid Vaccine

Another tragic vaccine death.

An inquest by authorities revealed that a 27-year-old engineer died from a blood clot on his brain days after his first Covid-19 shot, the BBC reported.

 

Jack Last, of Stowmarket, received the vaccination on March 30, 2021. A week later, he complained of headache and nausea, according to testimony given in Ipswich court.

On April 10, a CT scan was performed, and the results showed that Mr. Last had a cerebral venous sinus thrombosis or blood clot.

 

He had surgery and therapy, but on April 20 of last year, he passed away at Addenbrooke’s Hospital.

More from The Independent:

Mr. Last, from Stowmarket, Suffolk , enjoyed canyoning and bungee jumping and was previously described as “fit as ever”.

His sister Jasmine Last said the family had instructed solicitors to lead inquest proceedings on their behalf.

Last year, Ms. Last said she believed her brother’s death was linked to the AstraZeneca vaccine.

She told a reporter: “We’re waiting for the post-mortem results and the inquest date to be confirmed – but we do believe that his death was linked to the vaccine.

“It was very unusual for Jack to feel unwell at all. To my knowledge, he had never had a day off work due to illness.”

The inquest, at Suffolk Coroners’ Court, was adjourned pending a pre-inquest review.

The Gateway Pundit reported a similar case where a 26-year-old graduate from Coventry University died from a blood clot on his brain after receiving the AstraZeneca vaccine. An inquest heard that the automotive design graduate was given out-of-date information about the risks of blood clots.

What do you think?

Written by colinnew

Leave a Reply

Your email address will not be published. Required fields are marked *

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy: a retrospective analysis of January–April, 2022

Pfizer’s Clinical Trial Exposed in Devastating Editorial Kids ‘More Likely’ to Get Severe Covid with Vaccines

Pfizer’s Clinical Trial Exposed in Devastating Editorial: Kids ‘More Likely’ to Get Severe Covid with Vaccines